A Somatic Mutation in HIF‐2α Affects Glucose and Lipid Metabolism via CD36 and Ceramide
The FASEB Journal, Volume 40, Issue 1, 15 January 2026.A mutation within the C‐terminal transactivation domain of HIF‐2α enhances Cd36 expression by increased transactivation activity, leading to ceramide accumulation and disruption of glucose and lipid metabolism. Inhibition of ceramide synthesis by myriocin reduces ceramide levels and ameliorates these metabolic disturbances.
Feiqiong Gao +9 more
wiley +1 more source
Sphingosine 1-phosphate signalling in cancer stem cells. [PDF]
OncogenesisPowell JA, Pitson SM.
europepmc +1 more source
New insights into the crosstalk between endocannabinoids and sphingosine-1-phosphate. [PDF]
J Biol ChemRapino C +5 more
europepmc +1 more source
Computational screening and in vitro evaluation of sphingosine-1-phosphate analogues as therapeutics for Non-Hodgkin's lymphoma. [PDF]
Sci RepAl Awadh AA.
europepmc +1 more source
Sphingosine-1-phosphate receptor modulators in ulcerative colitis - a narrative review of current evidence and practical considerations. [PDF]
Drugs ContextKuriakose Kuzhiyanjal AJ +3 more
europepmc +1 more source
Sphingosine-1-phosphate receptor 2 inhibition ameliorates familial exudative vitreoretinopathy models. [PDF]
J Biol ChemFeridooni HA +7 more
europepmc +1 more source
The Involvement of Ceramide, Sphingosine-1-Phosphate and Ganglioside GM1 in Regulating Some Nervous System Functions. [PDF]
Int J Mol SciGiussani P, Mauri L, Sonnino S.
europepmc +1 more source
Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney Disease. [PDF]
J Cell PhysiolSkafi N +16 more
europepmc +1 more source